Tumor-related symptoms (TRS) assessment in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with gefitinib or erlotinib: Preliminary results of an observational study.

e20619 Background: Edmonton Symptoms Assessment Scale (ESAS) is a validated tool in palliative care, which evaluates physical symptoms through a numeric scale (0-10). Symptoms improvement as a pred...